|
Characteristic
|
Patients with TDR
|
Patients without TDR
|
OR (95% CI)
|
p-value
|
|---|
|
Number (%)
|
Number (%)
|
|---|
| |
N=19
|
N=136
| | |
|---|
|
Country of Birth
| | | | |
|
Canada
|
12 (63.2%)
|
79 (58.1%)
|
1.44 (0.47, 4.62)
|
0.48
|
|
Other
|
7 (36.8%)
|
57 (41.9%)
|
|
Gender
| | | | |
|
Male
|
18 (94.7%)
|
97 (71.3%)
|
7.18 (1.06, 309.13)
|
0.03
|
|
Female
|
1 (5.3%)
|
39 (28.7%)
|
|
Mean age (range)
|
38 (23-49)
|
37 (18-70)
| |
0.73
|
|
Exposure Category
| | | | |
|
MSM
|
13 (68.4%)
|
48 (35.3%)
| | |
|
IDU
|
1 (5.3%)
|
17 (12.5%)
| | |
|
MSM/IDU
|
1 (5.3%)
|
1 (0.7%)
| | |
|
HIV endemic
|
2 (10.5%)
|
32 (23.5%)
| | |
|
Heterosexual
|
0
|
35 (25.7%)
| | |
|
Other
|
0
|
1 (0.7%)
| | |
|
Unknown
|
2 (10.5%)
|
2 (1.5%)
| | |
|
MSM
|
13 (68.4%)
|
48 (35.3%)
|
3.97 (1.30, 12.63)
|
0.005
|
|
All other
|
6 (31.6%)
|
88 (64.7%)
|
|
Clade
| | | | |
|
B
|
18(94.7%)
|
88 (64.7%)
|
9.73 (1.45,417.43)
|
0.009
|
|
Non-B
|
1 (5.3%)
|
48 (35.3%)
|
|
CD4 Count
| | | | |
|
<200
|
6 (31.6%)
|
41 (30.1%)
| |
0.97
|
|
200-500
|
8 (42.1%)
|
64 (47.1%)
| |
|
>500
|
5 (26.3%)
|
29 (21.3%)
| |
|
Unknown
|
0
|
2 (1.5%)
| |
|
Viral Load
| | | | |
|
<5,000
|
5 (21.1%)
|
36 (27.2%)
| |
0.37
|
|
5,000-10,000
|
3 (15.8%)
|
13 (9.6%)
| |
|
10,000-100,000
|
8 (47.4%)
|
57 (41.2%)
| |
|
>100,000
|
2 (10.5%)
|
29 (21.3%)
| |
|
Unknown
|
1 (5.3%)
|
1 (0.7%)
| |
|
Time Between Diagnosis and Genotype
| | | |
0.07*
|
|
<6 months
|
17 (89.5%)
|
88 (64.7%)
| |
|
6-12 months
|
0
|
7 (5.1%)
| |
|
>12 months
|
1 (5.3%)
|
34 (25.5%)
| |
|
Unknown
|
1 (5.3%)
|
7 (5.1%)
| |
- * Unknowns removed from analysis.
- * “Zero” cell adjustments made in calculations.
